Montfort-THM commercialization agreement

In continuum to our collaboration, Montfort signs a commercialization agreement with Tel Hashomer Medical Research, Infrastructure and Services Ltd (THM) for the development of AppTUG-based NPH diagnosis tool. By using AppTUG, before and after lumbar puncture (LP), we are able to accurately measure the impact of the intracranial pressure reduction.

Read More...

AppTUG launched in Assaf Harofeh hospital

Montfort starts working in Assaf Harofeh hospital in collaboration with The Sagol Center for Hyperbaric Medicine and research. The hyperbaric chambers in the Sagol Center provide High Pressure Oxygen Treatment (HBOT), which helps treating patients who suffer from different acute or chronic medical conditions. AppTUG is used for motor assessments of patients who suffer from

Read More...

Monitoring in Shaare Zedek Medical Center

Montfort AppTUG is being used in the Gaucher’s disease center in Shaare Zedek Medical Center, Jerusalem, Israel. Gaucher’s disease is caused by a recessive mutation in the GBA gene located on chromosome 1 and affects both males and females. About one in 100 people in the United States are carriers of the most common type

Read More...